ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Hansa Biopharma AB · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
kidney transplant rejection, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 812277
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.